BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33973045)

  • 1. The selective 5-HT
    Głuch-Lutwin M; Sałaciak K; Gawalska A; Jamrozik M; Sniecikowska J; Newman-Tancredi A; Kołaczkowski M; Pytka K
    Psychopharmacology (Berl); 2021 Aug; 238(8):2249-2260. PubMed ID: 33973045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of Serotonin 5-HT
    Jastrzębska-Więsek M; Partyka A; Rychtyk J; Śniecikowska J; Kołaczkowski M; Wesołowska A; Varney MA; Newman-Tancredi A
    ACS Chem Neurosci; 2018 May; 9(5):1040-1050. PubMed ID: 29266914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NLX-101, a highly selective 5-HT
    Depoortère R; Auclair AL; Newman-Tancredi A
    Behav Brain Res; 2021 Mar; 401():113082. PubMed ID: 33358917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortical 5-hydroxytryptamine 1A receptor biased agonist, NLX-101, displays rapid-acting antidepressant-like properties in the rat chronic mild stress model.
    Depoortère R; Papp M; Gruca P; Lason-Tyburkiewicz M; Niemczyk M; Varney MA; Newman-Tancredi A
    J Psychopharmacol; 2019 Nov; 33(11):1456-1466. PubMed ID: 31290370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 5-HT
    Głuch-Lutwin M; Sałaciak K; Pytka K; Gawalska A; Jamrozik M; Śniecikowska J; Kołaczkowski M; Depoortère RY; Newman-Tancredi A
    Behav Brain Res; 2023 Feb; 438():114207. PubMed ID: 36368443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-aggressive effects of the selective high-efficacy 'biased' 5-HT₁A receptor agonists F15599 and F13714 in male WTG rats.
    de Boer SF; Newman-Tancredi A
    Psychopharmacology (Berl); 2016 Mar; 233(6):937-47. PubMed ID: 26694810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the Serotonin 5-HT
    Newman-Tancredi A; Varney MA; McCreary AC
    Neurochem Res; 2018 May; 43(5):1035-1046. PubMed ID: 29572645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of serotonin 5-HT(1A) receptor 'biased agonists' in rat models of Parkinson's disease and L-DOPA-induced dyskinesia.
    Iderberg H; McCreary AC; Varney MA; Cenci MA; Newman-Tancredi A
    Neuropharmacology; 2015 Jun; 93():52-67. PubMed ID: 25645393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminative stimulus properties of the 5-HT1A receptor biased agonists NLX-101 and F13714, in rats trained to discriminate 8-OH-DPAT from saline.
    Broadbear JH; Depoortere RY; Vacy K; Ralph D; Tunstall BJ; Newman-Tancredi A
    Behav Pharmacol; 2021 Dec; 32(8):652-659. PubMed ID: 34751175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. F15599, a highly selective post-synaptic 5-HT(1A) receptor agonist: in-vivo profile in behavioural models of antidepressant and serotonergic activity.
    Assié MB; Bardin L; Auclair AL; Carilla-Durand E; Depoortère R; Koek W; Kleven MS; Colpaert F; Vacher B; Newman-Tancredi A
    Int J Neuropsychopharmacol; 2010 Nov; 13(10):1285-98. PubMed ID: 20059805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marble Burying in NMRI Male Mice Is Preferentially Sensitive to Pre- Versus Postsynaptic 5-HT1A Receptor Biased Agonists.
    Depoortere R; Bardin L; Auclair AL; Bruins Slot LA; Newman-Tancredi A
    Pharmacology; 2021; 106(1-2):114-118. PubMed ID: 32950991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Divergent effects of the 'biased' 5-HT1 A receptor agonists F15599 and F13714 in a novel object pattern separation task.
    van Goethem NP; Schreiber R; Newman-Tancredi A; Varney M; Prickaerts J
    Br J Pharmacol; 2015 May; 172(10):2532-43. PubMed ID: 25572672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing the differential roles of striatal 5-HT
    Meadows SM; Chambers NE; Conti MM; Bossert SC; Tasber C; Sheena E; Varney M; Newman-Tancredi A; Bishop C
    Exp Neurol; 2017 Jun; 292():168-178. PubMed ID: 28342749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferential in vivo action of F15599, a novel 5-HT(1A) receptor agonist, at postsynaptic 5-HT(1A) receptors.
    Lladó-Pelfort L; Assié MB; Newman-Tancredi A; Artigas F; Celada P
    Br J Pharmacol; 2010 Aug; 160(8):1929-40. PubMed ID: 20649591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NLX-112, a highly selective 5-HT
    Newman-Tancredi A; Bardin L; Auclair A; Colpaert F; Depoortère R; Varney MA
    Brain Res; 2018 Jun; 1688():1-7. PubMed ID: 29555239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. F15599, a preferential post-synaptic 5-HT1A receptor agonist: activity in models of cognition in comparison with reference 5-HT1A receptor agonists.
    Depoortère R; Auclair AL; Bardin L; Colpaert FC; Vacher B; Newman-Tancredi A
    Eur Neuropsychopharmacol; 2010 Sep; 20(9):641-54. PubMed ID: 20488670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin 5-HT
    Depoortère R; Bardin L; Varney MA; Newman-Tancredi A
    ACS Chem Neurosci; 2019 Jul; 10(7):3101-3107. PubMed ID: 30929419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biased 5-HT
    van Hagen BTJ; van Goethem NP; Nelissen E; Paes D; Koymans K; van Hoof S; Schreiber R; Varney M; Newman-Tancredi A; Prickaerts J
    Mol Cell Neurosci; 2022 May; 120():103719. PubMed ID: 35283305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signal transduction and functional selectivity of F15599, a preferential post-synaptic 5-HT1A receptor agonist.
    Newman-Tancredi A; Martel JC; Assié MB; Buritova J; Lauressergues E; Cosi C; Heusler P; Bruins Slot L; Colpaert FC; Vacher B; Cussac D
    Br J Pharmacol; 2009 Jan; 156(2):338-53. PubMed ID: 19154445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggression-reducing effects of F15599, a novel selective 5-HT1A receptor agonist, after microinjection into the ventral orbital prefrontal cortex, but not in infralimbic cortex in male mice.
    Stein DJ; Miczek KA; Lucion AB; de Almeida RM
    Psychopharmacology (Berl); 2013 Dec; 230(3):375-87. PubMed ID: 23828155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.